Methadone and buprenorphine for opioid dependence during pregnancy: A retrospective cohort study

Journal of Addiction Medicine

Volumn 9, Issue 2, 2015, Pages 81-86

  Meyer, Marjorie C ^a   Johnston, Anne M ^a   Crocker, Abigail M ^b   Heil, Sarah H ^a  

^a UNIVERSITY OF VERMONT   (United States)

^b NONE   (United States)

Author keywords

buprenorphine; methadone; opioid dependence; pregnancy

Indexed keywords

BUPRENORPHINE; METHADONE; NARCOTIC ANALGESIC AGENT;

ADULT; COMPARATIVE STUDY; FEMALE; HUMAN; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDY; YOUNG ADULT;

ADULT; ANALGESICS, OPIOID; BUPRENORPHINE; FEMALE; HUMANS; METHADONE; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84941041313     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0000000000000092     Document Type: Article

References (23)

1. Bakstad B, Sarfi M, Welle-Strand GK, Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study. Eur Addict Res 2009; 15 (3): 128-134
2. Binder T, Vavrinkova B,. Prospective randomized comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department. Neuro Endocrinol Lett 2008; 29 (1): 80-86
3. Fischer G, Ortner R, Rohrmeister K, Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study. Addiction 2006; 101 (2): 275-281
4. Hulse GK, Milne E, English DR, The relationship between maternal use of heroin and methadone and infant birth weight. Addiction 1997; 92 (11): 1571-1579
5. Ioannidis JP, Haidich AB, Pappa M, Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA 2001; 286 (7): 821-830
6. Jansson LM, Velez M, Harrow C,. The opioid-exposed newborn: assessment and pharmacologic management. J Opioid Manag 2009; 5 (1): 47-55
7. Jones HE, Heil SH, Baewert A, Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review. Addiction 2012; 107 (suppl 1): 5-27
8. Jones HE, Johnson RE, Jasinski DR, Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Depend 2005; 79 (1): 1-10
9. Jones HE, Kaltenbach K, Heil SH, Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med 2010; 363 (24): 2320-2331
10. Jones HE, O'Grady KE, Malfi D, Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes. Am J Addict 2008; 17 (5): 372-386
11. Kakko J, Gronbladh L, Svanborg KD, A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial. Am J Psychiatry 2007; 164 (5): 797-803
12. Kakko J, Heilig M, Sarman I,. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series. Drug Alcohol Depend 2008; 96 (1-2): 69-78
13. Kaltenbach K, Berghella V, Finnegan L,. Opioid dependence during pregnancy. Effects and management. Obstet Gynecol Clin North Am 1998; 25 (1): 139-151
14. Kandall SR, Albin S, Gartner LM, The narcotic-dependent mother: fetal and neonatal consequences. Early Hum Dev 1977; 1 (2): 159-169
15. Kotelchuck M,. The Adequacy of Prenatal Care Utilization Index: its US distribution and association with low birthweight. Am J Public Health 1994; 84 (9): 1486-1489
16. Lacroix I, Berrebi A, Garipuy D, Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study. Eur J Clin Pharmacol 2011; 67 (10): 1053-1059
17. Lejeune C, Simmat-Durand L, Gourarier L, Groupe d'Etudes Grossesse et Addictions (GEGA). Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenorphine substitution. Drug Alcohol Depend 2006; 82 (3): 250-257
18. Lester BM, Andreozzi L, Appiah L,. Substance use during pregnancy: time for policy to catch up with research. Harm Reduct J 2004; 1 (1): 5
19. Lifschitz MH, Wilson GS, Smith EO, Factors affecting head growth and intellectual function in children of drug addicts. Pediatrics 1985; 75 (2): 269-274
20. Messinger DS, Bauer CR, Das A, The maternal lifestyle study: cognitive, motor, and behavioral outcomes of cocaine-exposed and opiate-exposed infants through three years of age. Pediatrics 2004; 113 (6): 1677-1685
21. Peachey JE, Lei H,. Assessment of opioid dependence with naloxone. Br J Addict 1988; 83 (2): 193-201
22. Substance Abuse and Mental Health Services Administration. Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction. A Treatment Improvement Protocol (TIP) 40. SAMHSA; 2004
23. Winklbaur B, Kopf N, Ebner N, Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: a knowledge synthesis for better treatment for women and neonates. Addiction 2008; 103 (9): 1429-1440